Cargando…
Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023546/ https://www.ncbi.nlm.nih.gov/pubmed/29735910 http://dx.doi.org/10.3390/jpm8020017 |
_version_ | 1783335894122496000 |
---|---|
author | Antoniou, Miranta Kolamunnage-Dona, Ruwanthi Jorgensen, Andrea L. |
author_facet | Antoniou, Miranta Kolamunnage-Dona, Ruwanthi Jorgensen, Andrea L. |
author_sort | Antoniou, Miranta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6023546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60235462018-07-08 Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 Antoniou, Miranta Kolamunnage-Dona, Ruwanthi Jorgensen, Andrea L. J Pers Med Correction MDPI 2018-05-07 /pmc/articles/PMC6023546/ /pubmed/29735910 http://dx.doi.org/10.3390/jpm8020017 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Antoniou, Miranta Kolamunnage-Dona, Ruwanthi Jorgensen, Andrea L. Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title | Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title_full | Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title_fullStr | Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title_full_unstemmed | Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title_short | Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1 |
title_sort | correction: antoniou, m.; et al. biomarker-guided non-adaptive trial designs in phase ii and phase iii: a methodological review. j. pers. med. 2017, 7, 1 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023546/ https://www.ncbi.nlm.nih.gov/pubmed/29735910 http://dx.doi.org/10.3390/jpm8020017 |
work_keys_str_mv | AT antonioumiranta correctionantonioumetalbiomarkerguidednonadaptivetrialdesignsinphaseiiandphaseiiiamethodologicalreviewjpersmed201771 AT kolamunnagedonaruwanthi correctionantonioumetalbiomarkerguidednonadaptivetrialdesignsinphaseiiandphaseiiiamethodologicalreviewjpersmed201771 AT jorgensenandreal correctionantonioumetalbiomarkerguidednonadaptivetrialdesignsinphaseiiandphaseiiiamethodologicalreviewjpersmed201771 |